Almirincomb 4 mg/5 mg tablete
| Name | Almirincomb 4 mg/5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-203071244 |
| Active Substance | perindopril-tert-butilamin amlodipinbesilat |
| Composition | jedna tableta sadrži 4 mg perindopril-tert-butilamina što odgovara 3,34 mg perindoprila i 5 mg amlodipina (u obliku besilata) |
| Pharmaceutical Form | tableta |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska Jadran Galenski laboratorij d.d., Rijeka, Hrvatska |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 28.11.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/24-02/09 |
| Registration Number | 381-12-01/286-24-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BB04 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
